Aladdin Healthcare Technologies SE
Aladdin Healthcare Technologies achieves OTCQX listing in the USA
DGAP-News: Aladdin Healthcare Technologies SE
/ Key word(s): Miscellaneous
Aladdin Healthcare Technologies achieves OTCQX listing in the USA – Aladdin shares enter world’s largest technology market BERLIN/LONDON, August 31, 2020 – Aladdin Healthcare Technologies SE (“Aladdin”, ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, has applied and qualified to trade on the OTCQX market maintaining its listing on the Düsseldorf and the Frankfurt Stock Exchange. This listing will enhance the availability and profile of Aladdin shares to the international investing community. “With our inclusion in the US stock market, we are now moving into the world’s best capital market for healthcare technology taking a decisive step to accompany our rapidly growing business. As a leading developer of AI healthcare diagnostics and drug discovery applications for age-related diseases, we see it as a great opportunity to present our business model and its growth prospects to investors who are attracted to innovative companies with rapid growth potential,” said Wade Menpes-Smith, CEO of Aladdin Healthcare Technologies SE. About Aladdin Healthcare Technologies SE Website Link: www.aladdinid.com For further information: Aladdin Healthcare Technologies Ltd. Contact Press
31.08.2020 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Aladdin Healthcare Technologies SE |
Unter den Linden 10 | |
10117 Berlin | |
Germany | |
Phone: | 030 700140449 |
E-mail: | info@aladdinid.com |
Internet: | www.aladdinid.com |
ISIN: | DE000A12ULL2 |
WKN: | A12ULL |
Listed: | Regulated Market in Dusseldorf |
EQS News ID: | 1125023 |
End of News | DGAP News Service |